Contemporary use of cardiac imaging for COVID-19 patients: a three center experience defining a potential role for cardiac MRI.
COVID-19
Cardiac MRI
Coronavirus
SARS-CoV-2
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
23
09
2020
accepted:
17
12
2020
pubmed:
10
2
2021
medline:
25
5
2021
entrez:
9
2
2021
Statut:
ppublish
Résumé
The pandemic of coronavirus disease 2019 (COVID-19) secondary to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has bestowed an unprecedented challenge upon us, resulting in an international public health emergency. COVID-19 has already resulted in > 1,600,000 deaths worldwide and the fear of a global economic collapse. SARS-CoV-2 is notorious for causing acute respiratory distress syndrome, however emerging literature suggests various dreaded cardiac manifestations associated with high mortality. The mechanism of myocardial damage in COVID-19 is unclear but thought to be multifactorial and mainly driven by the host's immune response (cytokine storm), hypoxemia and direct myocardial injury by the virus. Cardiac manifestations from COVID-19 include but are not limited to, acute myocardial injury, cardiac arrhythmias, congestive heart failure and acute coronary syndrome. Cardiac imaging is paramount to appropriately diagnose and manage the cardiac manifestations of COVID-19. Herein, we present cardiac imaging findings of COVID-19 patients with biomarker and imaging confirmed myocarditis to provide insight regarding the variable manifestations of COVID-19 myocarditis via Cardiac MRI (CMR) coupled with CMR-edema education along with recommendations on how to incorporate advanced CMR into the clinicians' COVID-19 armamentarium.
Identifiants
pubmed: 33559800
doi: 10.1007/s10554-020-02139-2
pii: 10.1007/s10554-020-02139-2
pmc: PMC7871025
doi:
Types de publication
Journal Article
Multicenter Study
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1721-1733Références
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Mil Med Res 7(1):11. https://doi.org/10.1186/s40779-020-00240-0
doi: 10.1186/s40779-020-00240-0
pubmed: 32169119
pmcid: 32169119
CDC (2020) https://www.cdc.gov/coronavirus/2019-ncov/index.html Accessed 15 Dec 2020
Alhogbani T (2016) Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med 36(1):78–80. https://doi.org/10.5144/0256-4947.2016.78
doi: 10.5144/0256-4947.2016.78
pubmed: 26922692
pmcid: 6074274
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
doi: 10.1016/S0140-6736(20)30183-5
pubmed: 31986264
pmcid: 31986264
Chen C, Zhou Y, Wang DW (2020) SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz 45(3):230–232. https://doi.org/10.1007/s00059-020-04909-z
doi: 10.1007/s00059-020-04909-z
pubmed: 32140732
Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M (2020) Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1096
doi: 10.1001/jamacardio.2020.1096
pubmed: 32845276
pmcid: 7364333
China. NHCotPsRo Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition). http://en.nhc.gov.cn/ Accessed 15 Dec 2020
Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, Liu W, Zeng H, Tao Q, Xia L (2020) Cardiac involvement in recovered COVID-19 patients identified by magnetic resonance imaging. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2020.05.004
doi: 10.1016/j.jcmg.2020.05.004
pubmed: 33221213
pmcid: 7214335
Zheng YY, Ma YT, Zhang JY, Xie X (2020) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17(5):259–260. https://doi.org/10.1038/s41569-020-0360-5
doi: 10.1038/s41569-020-0360-5
pubmed: 32139904
pmcid: 32139904
Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, Madhur MS, Tomaszewski M, Maffia P, D’Acquisto F, Nicklin SA, Marian AJ, Nosalski R, Murray EC, Guzik B, Berry C, Touyz RM, Kreutz R, Wang DW, Bhella D, Sagliocco O, Crea F, Thomson EC, McInnes IB (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. https://doi.org/10.1093/cvr/cvaa106
doi: 10.1093/cvr/cvaa106
pubmed: 33245753
pmcid: 7454368
Musher DM, Abers MS, Corrales-Medina VF (2019) Acute infection and myocardial infarction. N Engl J Med 380(2):171–176. https://doi.org/10.1056/NEJMra1808137
doi: 10.1056/NEJMra1808137
pubmed: 30625066
Chen L, Li X, Chen M, Feng Y, Xiong C (2020) The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res 116(6):1097–1100. https://doi.org/10.1093/cvr/cvaa078
doi: 10.1093/cvr/cvaa078
pubmed: 32227090
Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Helio T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM, European Society of Cardiology Working Group on M, Pericardial D (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(33):2636–2648
doi: 10.1093/eurheartj/eht210
Han Y, Chen T, Bryant J, Bucciarelli-Ducci C, Dyke C, Elliott MD, Ferrari VA, Friedrich MG, Lawton C, Manning WJ, Ordovas K, Plein S, Powell AJ, Raman SV, Carr J (2020) Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic. J Cardiovasc Magn Reson 22(1):26. https://doi.org/10.1186/s12968-020-00628-w
doi: 10.1186/s12968-020-00628-w
pubmed: 32340614
pmcid: 7184243
Skulstad H, Cosyns B, Popescu BA, Galderisi M, Salvo GD, Donal E, Petersen S, Gimelli A, Haugaa KH, Muraru D, Almeida AG, Schulz-Menger J, Dweck MR, Pontone G, Sade LE, Gerber B, Maurovich-Horvat P, Bharucha T, Cameli M, Magne J, Westwood M, Maurer G, Edvardsen T (2020) COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging. https://doi.org/10.1093/ehjci/jeaa072
doi: 10.1093/ehjci/jeaa072
pubmed: 32242891
pmcid: 7184341
Kirkpatrick JN, Mitchell C, Taub C, Kort S, Hung J, Swaminathan M (2020) ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2020.04.002
doi: 10.1016/j.jacc.2020.04.002
pubmed: 33243384
pmcid: 7324097
Mahmud E, Dauerman HL, Welt FG, Messenger JC, Rao SV, Grines C, Mattu A, Kirtane AJ, Jauhar R, Meraj P, Rokos IC, Rumsfeld JS, Henry TD (2020) Management of acute myocardial infarction during the COVID-19 pandemic. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2020.04.039
doi: 10.1016/j.jacc.2020.04.039
pubmed: 32380033
pmcid: 7198172
Skali H, Murthy VL, Al-Mallah MH, Bateman TM, Beanlands R, Better N, Calnon DA, Dilsizian V, Gimelli A, Pagnanelli R, Polk DM, Soman P, Thompson RC, Einstein AJ, Dorbala S (2020) Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: an Information Statement from ASNC and SNMMI. J Nucl Cardiol. https://doi.org/10.1007/s12350-020-02123-2
doi: 10.1007/s12350-020-02123-2
pubmed: 33025475
pmcid: 7538366
Biere L, Piriou N, Ernande L, Rouzet F, Lairez O (2019) Imaging of myocarditis and inflammatory cardiomyopathies. Arch Cardiovasc Dis 112(10):630–641. https://doi.org/10.1016/j.acvd.2019.05.007
doi: 10.1016/j.acvd.2019.05.007
pubmed: 31494082
Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, Gal Oz A, Rothschild E, Baruch G, Peri Y, Arbel Y, Topilsky Y (2020) The spectrum of cardiac manifestations in coronavirus disease 2019 (COVID-19)—a Systematic Echocardiographic Study. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.120.047971
doi: 10.1161/CIRCULATIONAHA.120.047971
pubmed: 32469253
pmcid: 7382541
Cizgici AY, Zencirkiran Agus H, Yildiz M (2020) COVID-19 myopericarditis: It should be kept in mind in today’s conditions. Am J Emerg Med. https://doi.org/10.1016/j.ajem.2020.04.080
doi: 10.1016/j.ajem.2020.04.080
pubmed: 32360119
pmcid: 7187845
Doyen D, Moceri P, Ducreux D, Dellamonica J (2020) Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet 395(10235):1516. https://doi.org/10.1016/S0140-6736(20)30912-0
doi: 10.1016/S0140-6736(20)30912-0
pubmed: 32334650
pmcid: 7180035
Hu H, Ma F, Wei X, Fang Y (2020) Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa190
doi: 10.1093/eurheartj/ehaa190
pubmed: 32725123
pmcid: 7557450
Hua A, O’Gallagher K, Sado D, Byrne J (2020) Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa253
doi: 10.1093/eurheartj/ehaa253
pubmed: 33180895
pmcid: 7184427
Kim IC, Kim JY, Kim HA, Han S (2020) COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa288
doi: 10.1093/eurheartj/ehaa288
pubmed: 33677513
pmcid: 7700757
Kir D, Mohan C, Sancassani R (2020) HEART BRAKE-An unusual cardiac manifestation of Coronavirus disease 2019 (COVID-19). JACC Case Rep. https://doi.org/10.1016/j.jaccas.2020.04.026
doi: 10.1016/j.jaccas.2020.04.026
pubmed: 32368756
pmcid: 7196413
Paul JF, Charles P, Richaud C, Caussin C, Diakov C (2020) Myocarditis revealing COVID-19 infection in a young patient. Eur Heart J Cardiovasc Imaging. https://doi.org/10.1093/ehjci/jeaa107
doi: 10.1093/ehjci/jeaa107
pubmed: 32402063
pmcid: 7197601
Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, De Cobelli F, Tresoldi M, Cappelletti AM, Basso C, Godino C, Esposito A (2020) Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa286
doi: 10.1093/eurheartj/ehaa286
pubmed: 32363406
pmcid: 7197551
Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, Wang LF, Gao H, Wang Y, Dong CF, Li YJ, Xie XJ, Feng C, Liu L (2020) First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. https://doi.org/10.1007/s15010-020-01424-5
doi: 10.1007/s15010-020-01424-5
pubmed: 32725595
pmcid: 7386384
Coyle J, Igbinomwanhia E, Sanchez-Nadales A, Danciu S, Chu C, Shah N (2020) A recovered case of COVID-19 myocarditis and ARDS treated with corticosteroids, tocilizumab, and experimental AT-001. JACC Case Rep. https://doi.org/10.1016/j.jaccas.2020.04.025
doi: 10.1016/j.jaccas.2020.04.025
pubmed: 32368755
pmcid: 7196388
Luetkens JA, Isaak A, Zimmer S, Nattermann J, Sprinkart AM, Boesecke C, Rieke GJ, Zachoval C, Heine A, Velten M, Duerr GD (2020) Diffuse myocardial inflammation in COVID-19 associated myocarditis detected by multiparametric cardiac magnetic resonance imaging. Circ Cardiovasc Imaging 13(5):e010897. https://doi.org/10.1161/CIRCIMAGING.120.010897
doi: 10.1161/CIRCIMAGING.120.010897
pubmed: 32397816
Beaudry JT, Dietrick B, Lammert DB, Constas A, McCaw J, Hammond J, Buendia M, Stein JE, Pekosz A, Schuette J, Mostafa HH, Hooper JE, Bernier M, Agwu A, Feldman LS (2020) Fatal SARS-CoV-2 inflammatory syndrome and myocarditis in an adolescent: a case report. Pediatr Infect Dis J. https://doi.org/10.1097/INF.0000000000002978
doi: 10.1097/INF.0000000000002978
Caraffa R, Marcolongo R, Bottio T, Rizzo S, Bifulco O, Bagozzi L, D’Onofrio A, Caforio ALP, Jorgji V, Basso C, Gerosa G (2020) Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic. ESC Heart Fail. https://doi.org/10.1002/ehf2.13028
doi: 10.1002/ehf2.13028
pubmed: 33225579
pmcid: 7753829
Othenin-Girard A, Regamey J, Lamoth F, Horisberger A, Glampedakis E, Epiney JB, Kuntzer T, de Leval L, Carballares M, Hurni CA, Rusca M, Pantet O, Di Bernardo S, Oddo M, Comte D, Piquilloud L (2020) Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult. Swiss Med Wkly 150:w20387. doi: https://doi.org/10.4414/smw.2020.20387
doi: 10.4414/smw.2020.20387
pubmed: 33181855
Tiwary T, Baiswar S, Jinnur P (2020) A rare case of COVID-19 myocarditis with cardiac tamponade in a young diabetic adult with renal failure. Cureus 12(11):e11632. https://doi.org/10.7759/cureus.11632
doi: 10.7759/cureus.11632
pubmed: 33240736
pmcid: 7681942
Panchal A, Kyvernitakis A, Biederman R (2020) An interesting case of COVID-19 induced reversed takotsubo cardiomyopathy and insight on cardiac biomarkers. Cureus 12(11):e11296. https://doi.org/10.7759/cureus.11296
doi: 10.7759/cureus.11296
pubmed: 33282573
pmcid: 7710340
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
doi: 10.1016/S0140-6736(20)30211-7
pubmed: 32007143
pmcid: 7135076
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 55(3):105924. https://doi.org/10.1016/j.ijantimicag.2020.105924
doi: 10.1016/j.ijantimicag.2020.105924
pubmed: 32081636
pmcid: 7127800
Saghazadeh A, Rezaei N (2020) Immune-epidemiological parameters of the novel coronavirus—a perspective. Expert Rev Clin Immunol. https://doi.org/10.1080/1744666X.2020.1750954
doi: 10.1080/1744666X.2020.1750954
pubmed: 32237901
pmcid: 7157951
Goitein O, Matetzky S, Beinart R, Di Segni E, Hod H, Bentancur A, Konen E (2009) Acute myocarditis: noninvasive evaluation with cardiac MRI and transthoracic echocardiography. AJR Am J Roentgenol 192(1):254–258. https://doi.org/10.2214/AJR.08.1281
doi: 10.2214/AJR.08.1281
pubmed: 19098207
Ferreira VM, Piechnik SK, Robson MD, Neubauer S, Karamitsos TD (2014) Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping. J Thorac Imaging 29(3):147–154. doi: https://doi.org/10.1097/RTI.0000000000000077
doi: 10.1097/RTI.0000000000000077
pubmed: 24576837
pmcid: 4252135
Friedrich MG (2008) Tissue characterization of acute myocardial infarction and myocarditis by cardiac magnetic resonance. JACC Cardiovasc Imaging 1(5):652–662. https://doi.org/10.1016/j.jcmg.2008.07.011
doi: 10.1016/j.jcmg.2008.07.011
pubmed: 19356496
Wang Q, Fang P, He R, Li M, Yu H, Zhou L, Yu Y, Wang F, Rong Y, Zhang Y, Peng N, Lin Y, Lu M, Zhu Y, Peng G, Rao L, Liu S (2020) O-GlcNAc transferase promotes influenza A virus–induced cytokine storm by targeting interferon regulatory factor–5. Sci Adv 6(16):eaaz7086. https://doi.org/10.1126/sciadv.aaz7086
doi: 10.1126/sciadv.aaz7086
pubmed: 32494619
pmcid: 7159909
Deftereos S, Giannopoulos G, Papoutsidakis N, Panagopoulou V, Kossyvakis C, Raisakis K, Cleman MW, Stefanadis C (2013) Colchicine and the heart: pushing the envelope. J Am Coll Cardiol 62(20):1817–1825. https://doi.org/10.1016/j.jacc.2013.08.726
doi: 10.1016/j.jacc.2013.08.726
pubmed: 24036026
Robertson S, Martinez GJ, Payet CA, Barraclough JY, Celermajer DS, Bursill C, Patel S (2016) Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. Clin Sci (Lond) 130(14):1237–1246. https://doi.org/10.1042/CS20160090
doi: 10.1042/CS20160090
Sabouraud A, Chappey O, Dupin T, Scherrmann JM (1994) Binding of colchicine and thiocolchicoside to human serum proteins and blood cells. Int J Clin Pharmacol Ther 32(8):429–432
pubmed: 7981928
Morgenstern D, Lisko J, Boniface NC, Mikolich BM, Mikolich JR (2016) Myocarditis and colchicine: a new perspective from cardiac MRI. J Cardiovasc Magn Reson 18(1):O100. https://doi.org/10.1186/1532-429X-18-S1-O100
doi: 10.1186/1532-429X-18-S1-O100
pmcid: 5032433
Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, Ibrahim H, Friedman GH, Thompson C, Alviar CL, Chadow HL, Fishman GI, Reynolds HR, Keller N, Hochman JS (2020) ST-segment elevation in patients with Covid-19—a case series. N Engl J Med. https://doi.org/10.1056/NEJMc2009020
doi: 10.1056/NEJMc2009020
pubmed: 32905690
pmcid: 7206932
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z (2020) Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1017
doi: 10.1001/jamacardio.2020.1017
pubmed: 32936268
pmcid: 7711564
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C (2020) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.0950
doi: 10.1001/jamacardio.2020.0950
pubmed: 32639516
pmcid: 7097841
Lippi G, Lavie CJ, Sanchis-Gomar F (2020) Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. https://doi.org/10.1016/j.pcad.2020.03.001
doi: 10.1016/j.pcad.2020.03.001
pubmed: 32659343
pmcid: 7348599
Shah MB, Doyle M, Farah V, Biederman RWW (2018) Echocardiography and cardiovascular MRI entwined within the imaging domain; uniting the two. A compendium for the echocardiographer. Echocardiography 35(4):551–558. https://doi.org/10.1111/echo.13862
doi: 10.1111/echo.13862
pubmed: 29611625
al. Te (2020) Colchicine coronavirus SARS-CoV2 Trial (COLCORONA) (COVID-19). Clinicaltrialsgov Identifier: NCT04322682